Cover Image

Pilot study of hepatic intraarterial fotemustine chemotherapy for liver metastases from uveal melanoma: a single-center experience with seven patients

Background. Uveal melanoma is characterized by a high frequency of hepatic metastases. For patients with liver metastases, who have a median survival of 5 to 7 months, surgery and systemic conventional chemotherapy have little to offer.

Saved in:
Bibliographic Details
Main Authors: Egerer, Gerlinde (Author) , Lehnert, Thomas (Author) , Max, Regina (Author) , Näher, Helmut (Author) , Keilholz, Ulrich (Author) , Ho, Anthony Dick (Author)
Format: Article (Journal)
Language:English
Published: February 2001
In: International journal of clinical oncology
Year: 2001, Volume: 6, Issue: 1, Pages: 25-28
ISSN:1437-7772
DOI:10.1007/PL00012075
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/PL00012075
Get full text
Author Notes:Gerlinde Egerer, Thomas Lehnert, Regina Max, Helmut Naeher, Ulrich Keilholz, Anthony D. Ho
Description
Summary:Background. Uveal melanoma is characterized by a high frequency of hepatic metastases. For patients with liver metastases, who have a median survival of 5 to 7 months, surgery and systemic conventional chemotherapy have little to offer.
Item Description:Gesehen am 21.12.2021
Physical Description:Online Resource
ISSN:1437-7772
DOI:10.1007/PL00012075

Similar Items